PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Czasopismo
2008 | 3 | 2 | 195-198
Tytuł artykułu

The prevalence of Parkinson’s disease among Vilnius inhabitants

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
In a hospital-based study we investigated the prevalence of Parkinson’s disease among inhabitants of the Vilnius city, the capital of Lithuania. The study group was selected from patients who were diagnosed with Parkinson’s disease during the time frame of 1978-2005. Patients’ time of diagnosis were based on the data of dispensary cards, registration journals and/or other documentation. A questionnaire and Mini Mental State Examination provided data for analysis on the conditions of the patients. The prevalence of Parkinson’s disease in Vilnius is 1.32/1000 inhabitants and is higher in men than in women (p < 0.05). The age of Parkinson’s disease onset in men and women is the same (63.77 ± 0.70 years). The rigidity-tremor form of Parkinson’s disease is the most frequent (76.8% of all cases). The PD prevalence rate in Vilnius inhabitants are close to the mean levels observed in studies made in Finland, Austria, Germany. The prevailing form of Parkinson’s disease is rigidity-tremor.
Wydawca

Czasopismo
Rocznik
Tom
3
Numer
2
Strony
195-198
Opis fizyczny
Daty
wydano
2008-06-01
online
2008-04-09
Twórcy
  • Institute of Experimental and Clinical Medicine at Vilnius University, Center of Gerontology and Rehabilitation, Vilnius, LT, 08420, Lithuania, vainetav@ktl.mii.lt
  • Institute of Experimental and Clinical Medicine at Vilnius University, Center of Gerontology and Rehabilitation, Vilnius, LT, 08420, Lithuania
  • Institute of Experimental and Clinical Medicine at Vilnius University, Center of Gerontology and Rehabilitation, Vilnius, LT, 08420, Lithuania
  • Institute of Experimental and Clinical Medicine at Vilnius University, Center of Gerontology and Rehabilitation, Vilnius, LT, 08420, Lithuania
Bibliografia
  • [1] Lang A.E., Lozano A.M., Medical progress: Parkinson’s disease. Part 1., N. Engl. J. Med., 1998, 339, 1044–1053 http://dx.doi.org/10.1056/NEJM199810083391506[Crossref]
  • [2] Nakashima K., Maeda M., Tabata M., Achachi Y., Kusumi M., Ohshiro H., Prognosis of Parkinson’s disease in Japan., Versicherungsmedizin., 1997, 49(4), 126–131
  • [3] Werner M., Fornadi F., Effect of early diagnosis and therapy on prognosis of Parkinson syndrome., Versicherungsmedizin., 1997, 49(4), 126–131 [PubMed]
  • [4] Ben-Sholomo Y., Descriptive epidemiology of Parkinson’s disease through proxy measures., Can. J. Neurol. Sci., 1996, 6(1), 279–284
  • [5] Pepper P.V., Goldstein M.K., Postoperative complications in Parkinson’s disease., J. Am. Geriatr. Soc., 1999, 47(8), 967–972 [Crossref]
  • [6] McCann S.J., LeCouteur D.G., Green A.C., Brayne C., Johnson A.G., Chan D., et al., The epidemiology of Parkinson’s disease in an Australian population., Neuroepidemiology., 1998, 17(6), 310–317 http://dx.doi.org/10.1159/000026185[Crossref]
  • [7] Mayeux R., Marder K., Cote L., Denaro J., Hemenegildo N., Mejia H., et al., The frequency of idiopatic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988-1993, Am. J. Epidemiol., 1995, 142(8), 820–827
  • [8] De Leest B.J., Goluke-Willemse G.A., Parkinsonizm. The differential diagnosis., Tijdschr. Gerontol. Geriatr., 1998, 9(5), 250–257
  • [9] Tanner C.M., Goldman S.M., Epidemiology of Parkinson’s disease., Neurol. Clin., 1996, 14(2), 317–336 http://dx.doi.org/10.1016/S0733-8619(05)70259-0[Crossref]
  • [10] Kuopio A.M., Marttila R.J., Helenius H., Rinne U.K., Changing epidemiology of Parkinson’s disease in southwestern Finland., Neurology., 1999, 52(2), 302–308 [Crossref][PubMed]
  • [11] Kusumi M., Nakashima K., Harada H., Nakayama H., Takahashi K., Epidemiology of Parkinson’s disease in Yonago City, Japan: comparison with a study caried out 12 years ago., Neuroepidemiology., 1996, 15(4), 201–207 http://dx.doi.org/10.1159/000109908[Crossref]
  • [12] Zhang Z.H., Roman G.C., Worldwide occurrence of Parkinson’s disease: an updated review., Neuroepidemiology., 1993, 12, 195–208 http://dx.doi.org/10.1159/000110318[Crossref]
  • [13] Zhang Z.H., Hong X., Huang J.B., Wang J.M., Wei J., et al., Is China a low risk area for Parkinson’s disease?, Mov. Disord., 1998, 13(Suppl 2), 79
  • [14] Calne D.B., Snow B.J., Lee C., Criteria for diagnosing Parkinson’s disease., Ann. Neurol., 1992, 32 (Suppl 1), S125–S127 http://dx.doi.org/10.1002/ana.410320721[Crossref]
  • [15] Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J., What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology., 1992, 42, 1142–1146 [Crossref][PubMed]
  • [16] Hughes A.J., Daniel S.E., Kilford L., Lees A.J., Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases., J. Neurol. Neurosurg. Psychiatry., 1992, 55, 181–184 http://dx.doi.org/10.1136/jnnp.55.3.181[Crossref]
  • [17] Cheryl H. Waters. Diagnosis and management of Parkinson’s disease. California, 1998
  • [18] Koller W.C., Montgomery E.B., Issues in the early diagnosis of Parkinson’s disease., Neurology., 1997, 49 (Suppl 1), S10–S25 [Crossref][PubMed]
  • [19] Negoro K, Morimatsu M., Clinical and MRI correlation in multiple system atrophy., No To Shinkei, 1994, 46, 473–478 [PubMed]
  • [20] Valeikiene V., Juozulynas A., The incidence of Parkinson’s disease among Vilnius inhabitants. Gerontologija., 2006, 7(3), 131–136
  • [21] Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., et al., Prevalence of parkinsonian signs and associated mortality in a community population of older people., N. Engl. J. Med., 1996, 334(2), 71–76 http://dx.doi.org/10.1056/NEJM199601113340202[Crossref]
  • [22] Ben-Shlomo Y., The epidemiology of Parkinson’s disease., Baillieres Clin. Neurol., 1997, 6(1), 55–68
  • [23] Maldonado R.G., The strange case of Dr Parkinson (A new look at ancient disease): English edition: Jean Lourse Sanders and Enrique Sauchez Vilchez., 1998
  • [24] Hofman A., Ott A., de Rijk M.C., Breteler M.M.B., Prevalence of Alzheimer’s disease, vascular dementia, Parkinson’s disease and epilepsy in a Dutch population study: The Rotterdam Study., Neuroepidemiology., 1995, 14, 312
  • [25] De Rijk M.C., Tzourio C., Breteler M.M., Dartigues J.F., Amaducci L., Lopez-Pousa S., et al., Prevalence of parkisonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease., J. Neurol. Neurosurg Psychiatry., 1997, 62(1), 10–15
  • [26] Mutch W.J., Dingwall-Fordyce I., Downie A.W., Downie A.W., Paterson J.G., Roy S.K., Parkinson’s disease in a Scottish city., Br. Med. J., 1986, 292, 534–536
  • [27] Martinez-Martin P., O’Brien C.F., Extending levodopa action. COMT inhibition., Neurology., 1998, 50(Suppl 6), S27–S32 [Crossref]
  • [28] Sveinbjornsdottir S., Gudmudsson G., Einarsson G., Epidemiology of Parkinson’s Disease (PD) in Iceland: the first 234 cases in a total population survey., Mov Disord., 1998, 13(Suppl 2), 142
  • [29] Maskowitz C.B., Kopiryzi M., Petrela M., Fahn S. Parkinson’s disease in Albania (1995-1996)., Mov Disord., 1998, 13(Suppl 2), 298
  • [30] Martinez-Martin P., Lens C., Franch O., et al., Costs of Parkinson’s disease in Spain. A pilot study in outpatients., Mov Disord., 1998, 13(Suppl 2), 62
  • [31] Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., et al., Prevalence of parkinsonian signs and associated mortality in a community population of older people., N. Engl. J. Med., 1996, 334(2), 71–76 http://dx.doi.org/10.1056/NEJM199601113340202[Crossref]
  • [32] Valeikiene V., Juozulynas A., Clinical data of Parkinson’s disease. Gerontologija., 2003, 4(2), 91–105
  • [33] Valeikiene V., Derkintyte M., Quality of life in Parkinson’s disease. Gerontologija., 2003, 4(1), 13–17
  • [34] Benito-Leon J., Bermejo-Pareja F., Rodriguez J., Molina J.A., Gabriel R., Morales J.M., The Neurological disorders in central Spain (NEDICES) study group. Prevalence of PD and other Parkinsonism in three elderly populations of central Spain. Mov Disord., 2003 Mar, 18(3), 267–274 http://dx.doi.org/10.1002/mds.10362[Crossref]
  • [35] Benito-Leon J., Bermejo-Pareja F., Morales-Gonzales J.M., Porta-Etessem J., Trincado R., Vega S., et al., The Neurological disorders in central Spain (NEDICES) study group. Incidence of PD and other Parkinsonism in three elderly populations of central Spain. Neurology., 2004 Mar, 9, 62(3), 734–741 [Crossref]
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_s11536-008-0014-1
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.